BioMS Medical (MS.TO) Updates University of Alberta Equity Position
4/30/2010 11:51:53 AM
More...
|
BioMS Medical (MS.TO) Announces 2009 Year End Results
3/17/2010 10:46:39 AM
More...
|
BioMS Medical (MS.TO) Reports Spectral Diagnostics (SDI.TO) Receives FDA Approval to Initiate Pivotal Trial and Closes Financing for $19.5 Million
3/3/2010 6:43:34 AM
More...
|
Spectral Diagnostics (SDI.TO) Raises $14 Million and Enters into Strategic Collaboration with BioMS Medical (MS.TO) to Commercialize Treatment for Sepsis
12/18/2009 7:16:16 AM
More...
|
BioMS Medical (MS.TO) Provides Corporate Update; Company will Not Pursue Further Late Stage Clinical Trials with Dirucotide in MS
12/18/2009 7:14:06 AM
More...
|
BioMS Medical (MS.TO) Announces Third Quarter 2009 Results
11/13/2009 9:55:58 AM
More...
|
BioMS Medical (MS.TO) Provides Update on Dirucotide And Eli Lilly and Company (LLY)
9/3/2009 1:44:25 PM
More...
|
AutoImmune, Inc. (AIMM) Release: Clinical Trial by Licensee Does Not Meet Primary Endpoint
7/31/2009 9:34:05 AM
More...
|
Eli Lilly and Company (LLY) (JOBS) and BioMS Medical (MS.TO) Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
7/28/2009 7:04:08 AM
More...
|
BioMS Medical (MS.TO) Announces Second Quarter 2009 Results
7/19/2009 10:58:01 PM
More...
|
|